On April 28, Ge Longhui | Mingchen Health (002919.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 1,638 billion yuan, an increase of 73.21%; net profit attributable to shareholders of listed companies was 70.3647 million yuan, up 177.15% year on year; net profit attributable to shareholders of listed companies was deducted from non-recurring profit and loss of 65.2297 million yuan to profit; basic earnings per share were 0.32 yuan/share. The company plans to distribute a cash dividend of 1.5 yuan (tax included) to all shareholders for every 10 shares, and use the capital reserve fund to transfer 2 shares for every 10 shares to all shareholders.